Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The SEAPORT 1 Study: An Open-label Exploratory Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of INZ-701 in Study Participants With End-Stage Kidney Disease Undergoing Hemodialysis

Next Previous
Search
Trial Profile

The SEAPORT 1 Study: An Open-label Exploratory Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of INZ-701 in Study Participants With End-Stage Kidney Disease Undergoing Hemodialysis

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 07 Feb 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs INZ-701 (Primary)
  • Indications Calciphylaxis
  • Focus Adverse reactions; Pharmacokinetics
  • Acronyms SEAPORT 1
  • Sponsors Inozyme Pharma

    • Most Recent Events

    • 05 Feb 2025 Status changed from active, no longer recruiting to completed.
    • 15 Nov 2024 Planned End Date changed from 1 Jan 2025 to 30 Nov 2024.
    • 05 Nov 2024 According to Inozyme Pharma media release, interim data from this trial were presented at the American Society of Nephrology's Kidney Week 2024 in San Diego.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top